Lymphangioleiomyomatosis—presence of receptor tyrosine kinases and the angiogenesis factor VEGF‐A as potential therapeutic targets

Ítems similars

• Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
  per: Hu, D E, et al.
  Publicat: (1995)
• Receptor Tyrosine Kinase-Mediated Angiogenesis
  per: Jeltsch, Michael, et al.
  Publicat: (2013)
• Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
  per: Watz, Henrik, et al.
  Publicat: (2014)
• Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib
  per: Ma, Jie, et al.
  Publicat: (2009)
• Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation
  per: Buharalioglu, Cuneyt K., et al.
  Publicat: (2011)